A detailed history of Kingsview Wealth Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Kingsview Wealth Management, LLC holds 21,208 shares of NVO stock, worth $3.03 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
21,208
Previous 2,266 835.92%
Holding current value
$3.03 Million
Previous $234,000 1063.68%
% of portfolio
0.07%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$102.11 - $135.92 $1.93 Million - $2.57 Million
18,942 Added 835.92%
21,208 $2.72 Million
Q4 2023

Feb 08, 2024

SELL
$87.78 - $105.45 $33,180 - $39,860
-378 Reduced 14.3%
2,266 $234,000
Q3 2023

Nov 07, 2023

BUY
$90.94 - $199.54 $240,445 - $527,583
2,644 New
2,644 $240,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $323B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Kingsview Wealth Management, LLC Portfolio

Follow Kingsview Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingsview Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kingsview Wealth Management, LLC with notifications on news.